Carisoprodol Tablet
Product Images NDC 70518-2800

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 70518-2800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carisoprodol 350mg 70518 2800 01

Carisoprodol 350 mg tablet label with a quantity of 90 tablets. The label shows the proprietary and generic name, dosage form as tablet, schedule C-IV, and indicates RX only. It includes NDC 70518-2800-01, repackaged by RemedyRepack Inc. The manufacturing source is Oxford Pharmaceuticals, LLC, Birmingham, AL. There are usage directions to see the package insert and storage instructions.*

FDA Label Image

Remedy_label (Remedy Label)

Carisoprodol 350 mg oral tablets packaging label by RemedyRepack Inc. The label indicates a quantity of 60 tablets, classified as Schedule IV (C-IV) controlled substance. It includes NDC 70518-2800-00 and notes repackaging by RemedyRepack Inc., Indiana, PA. Additional information includes storage instructions and prescription-only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.